Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)

Mol Genet Metab. 2017 Mar;120(3):278-287. doi: 10.1016/j.ymgme.2016.11.004. Epub 2016 Dec 27.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Pantothenate Kinase-Associated Neurodegeneration / diagnosis*
  • Pantothenate Kinase-Associated Neurodegeneration / drug therapy*
  • Pantothenate Kinase-Associated Neurodegeneration / genetics
  • Pantothenic Acid / therapeutic use
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Practice Guidelines as Topic*

Substances

  • Iron Chelating Agents
  • Pantothenic Acid
  • Phosphotransferases (Alcohol Group Acceptor)
  • pantothenate kinase